The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Pykett Mark Jerome since year 2005.
The trader's CIK number is 1278271.
At the time of this reporting, Pykett Mark Jerome is the CEO of Neoprobe Corp .
(stock ticker symbol NEOP).
See this page for all insider trading activities at Neoprobe Corp .
Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|---|
2014-05-09 | NAVB | Neoprobe Corp | Buy | 10,000 | 1.34 | 13,400 |
2014-03-10 | NAVB | Neoprobe Corp | Sale | 120,000 | 1.96 | 235,200 |
2013-11-08 | NAVB | Neoprobe Corp | Buy | 10,900 | 1.35 | 14,715 |
2013-03-15 | NAVB | Neoprobe Corp | Buy | 1,850 | 2.70 | 4,995 |
2012-09-11 | NAVB | Neoprobe Corp | Buy | 4,000 | 2.64 | 10,552 |
2011-08-22 | NEOP | Neoprobe Corp | Buy | 4,400 | 2.58 | 11,365 |
2004-05-24 | ANX | Adventrx Pharmaceuticals Inc | Buy | 500 | 2.08 | 1,040 |
2005-04-06 | ANX | Adventrx Pharmaceuticals Inc | Buy | 3,000 | 1.70 | 5,085 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pykett Mark Jerome (CEO of Neoprobe Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.